Literature DB >> 11428397

Identification and treatment of Moniliformis clarki (Acanthocephala) in cotton-topped tamarins (Saguinus oedipus).

M Weber1, R Junge.   

Abstract

Ten cotton-topped tamarins (Saguinus oedipus) were infected with Moniliformis clarki a parasitic acanthocephalan. One animal died of intestinal perforation and peritonitis before treatment was initiated. Five of the remaining tamarins were treated successfully with oral albendazole at either 50 mg/kg b.i.d. for 16 days or 100 mg/kg b.i.d. for 3 days, then repeated biweekly for four treatments. A less-intensive treatment regime of 50 mg/kg albendazole orally s.i.d. for 3 days and monthly repeated treatments was unsuccessful. Parasites were removed via surgical enterotomy from two animals, both of which continued to shed acanthocephalan eggs postoperatively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11428397     DOI: 10.1638/1042-7260(2000)031[0503:IATOMC]2.0.CO;2

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  3 in total

1.  Anti-parasite treatment removes negative effects of environmental pollutants on reproduction in an Arctic seabird.

Authors:  Jan O Bustnes; Kjell E Erikstad; Sveinn A Hanssen; Torkild Tveraa; Ivar Folstad; Janncehe U Skaare
Journal:  Proc Biol Sci       Date:  2006-12-22       Impact factor: 5.349

2.  Anti-parasite treatment results in decreased estimated survival with increasing lead (Pb) levels in the common eider Somateria mollissima.

Authors:  A Morrill; J F Provencher; H G Gilchrist; M L Mallory; M R Forbes
Journal:  Proc Biol Sci       Date:  2019-09-04       Impact factor: 5.349

3.  Identification of antiparasitic drug targets using a multi-omics workflow in the acanthocephalan model.

Authors:  Hanno Schmidt; Katharina Mauer; Manuel Glaser; Bahram Sayyaf Dezfuli; Sören Lukas Hellmann; Ana Lúcia Silva Gomes; Falk Butter; Rebecca C Wade; Thomas Hankeln; Holger Herlyn
Journal:  BMC Genomics       Date:  2022-09-30       Impact factor: 4.547

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.